Relafen 750, pharmacologically known as diclofenac potassium, presents a unique case from a biochemical approach. Its mechanism of action primarily involves the blocking of cyclooxygenase enzymes , specifically COX-2, producing a reduction in prostaglandin formation. This action effectively reduces discomfort and swelling associated with musculoske